Drug abuse: Newly-Emerging drugs and trends

Clinics in Laboratory Medicine

Volumn 32, Issue 3, 2012, Pages 407-414

  Davis, Gregory G ^a,b  

^a University of Alabama at Birmingham   (United States)

^b Jefferson County Coroner Medical Examiner   (United States)

Author keywords

Bath salts; Kratom; Piperazine; Salvia; Synthetic cannabinoids

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BATH SALT; CANNABINOID DERIVATIVE; CENTRAL STIMULANT AGENT; DESIGNER DRUG; DRONABINOL; KETAMINE; MEPHENTERMINE; METHOXETAMINE; OPIATE DERIVATIVE; PIPERAZINE DERIVATIVE; PSYCHEDELIC AGENT; SALVINORIN A; UNCLASSIFIED DRUG; VETERINARY DRUG; XYLAZINE;

DRUG ABUSE; DRUG MARKETING; DRUG MISUSE; DRUG TRAFFIC; HUMAN; INTERNET; KRATOM; MEDICINAL PLANT; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW; SALVIA; SUBSTANCE ABUSE;

EID: 84865593444     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2012.06.002     Document Type: Review

References (17)

1. Buchanan J.F., Brown C.R. 'Designer drugs'. A problem in clinical toxicology. Med Toxicol Adverse Drug Exp 1988, 3:1-17.
2. Emergency department visits after use of a drug sold as "bath salts" - Michigan, November 13, 2010-March 31, 2011. MMWR Morb Mortal Wkly Rep 2011, 60:624-627.
3. Prosser J.M., Nelson L.S. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012, 8:33-42.
4. Jerry J., Collins G., Streem D. Synthetic legal intoxicating drugs: The emerging 'incense' and 'bath salt' phenomenon. Cleve Clin J Med 2012, 79:258-264.
5. Rosenbaum C.D., Carreiro S.P., Babu K.M. Here today, gone tomorrow . . . and back again?. A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), Kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012, 8:15-32.
6. Hu X., Primack B.A., Barnett T.E., et al. College students and the use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy 2011, 6:16.
7. Ward J., Rhyee S., Plansky J., et al. Methoxetamine: a novel ketamine analog and growing health-care concern. Clin Toxicol (Phila) 2011, 49:874-875.
8. Corazza O., Schifano F., Simonato P., et al. Phenomenon of new drugs on the internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol 2012, 27:145-149.
9. Hofer K.E., Grager B., Müller D.M., et al. Ketamine-like effects after recreational use of methoxetamine. Ann Emerg Med 2012, 60(1):97-99.
10. Lange J.E., Reed M.B., Croff J.M.K., et al. College student use of Salvia divinorum. Drug Alcohol Depend 2008, 94:263-266.
11. Kronstrand R., Roman M., Thelander G., et al. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J Anal Toxicol 2011, 35:242-247.
12. Yokell M.A., Zaller N.D., Green T.C., et al. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev 2011, 4:28-41.
13. Torruella R.A. Xylazine (veterinary sedative) use in Puerto Rico. Subst Abuse Treat Prev Policy 2011, 6:7.
14. De Oliveira M.F., de Sousa H.F., Lima M.C.D., et al. Mephentermine: rediscovering its biology and use, misuse and their implications. Rev Bras Psiquiatr 2011, 33:98-99.
15. Wu L.-T., Blazer D.G. Illicit and nonmedical drug use among older adults: a review. J Aging Health 2011, 23:481-504.
16. Hilmer Sarah N., Ford Gary A. General principles of pharmacology In: Halter JB, Ouslander JG, Tinetti ME, et al, editors. Hazzard's geriatric medicine and gerontology. 6th edition, Accessed May 21, 2011. http://www.accessmedicine.com/content.aspx?aID=5107787.
17. Peters F.T., Martinez-Ramirez J.A. Analytical toxicology of emerging drugs of abuse. Ther Drug Monit 2010, 32:532-539.